NEET UG 2020: NTA releases answer key for medical entrance exam at ntaneet.nic.in, results likely by 12 Oct

-

NEET UG 2020: The answer key for the National Eligibility cum Entrance Test (NEET) UG 2020 has been released on Saturday by the National Testing Agency (NTA) on — ntaneet.nic.in. The medical entrance examination was conducted on 13 September in an offline mode at various centres across the country.

In its notification, the NTA said that the advanced answer keys for all the sets including E1 to E6, f1 to F6, G1 to G6, and H1 to H6 have been released.

"The candidates are advised to go through the same and keep themselves ready for challenges of the Draft Answer Keys which will be published shortly," the examination conducting body said.

A notice inviting challenge of the keys will be issued later, NTA mentioned, asking candidates not to email their responses or clarification regarding the keys.

A report by Careers 360 said candidates who wish to challenge the NEET answer key will be required to pay a non-refundable processing fee of Rs 1,000 per answer challenged. They will be required to provide detailed clarification against the challenges raise.

The NTA is expected to release NEET 2020 result by 12 October in online mode.

A report by The Times of India said the exam was conducted under stringent protocols amid the COVID-19 pandemic. Students were allotted different slots for the entry to ensure social distancing.

The entrance exam was originally scheduled for 3 May but it got postponed due to the COVID-19 pandemic.

NEET 2020 answer key: How to check

Step 1: Log on to NEET 2020 official website - ntaneet.nic.in

Step 2: Under News & Events section on the right hand side of the homepage, opt for the link that reads, "PUBLIC NOTICE: NATIONAL ELIGIBILITY CUM ENTRANCE TEST (UG) - 2020 ANSWER KEY."

Step 3: A new PDF document with answers will open on your screen.

Step 4: Verify your responses with the answer key and prepare a draft to raise objection, if any.

Here is the direct link to check NEET 2020 answer key.



from Firstpost India Latest News https://ift.tt/3mSXxqF
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more